MoneyWorks4Me

Shardaben Gulabdas Patel submits disclosure

31 Mar 2018 Evaluate

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shardaben Gulabdas Patel.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

618.00 6.10 (1.00%)
25-Aug-2026 14:40 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1912.15
Dr. Reddys Labs. 1185.00
Cipla 1415.70
Lupin 2174.00
Zydus Lifesciences 1112.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: